The Department of Neurology and Neurological Sciences at Stanford University School of Medicine, together with multiple academic medical centers and one industry partner (Medtronic) across the US, ...

New research shows adaptive deep brain stimulation is safe and effective in Parkinson care. Keep reading to see future treatment potential.

The device can precisely stimulate areas deep in the brain without surgery and could transform the treatment of Parkinson's and depression.

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy for Parkinson’s disease.

Medtronic plc’s Brainsense adaptive deep brain stimulation system has been shown to be tolerable, effective and safe for long-term use at home in people with Parkinson’s disease. A study published in ...

NEW findings indicate that postoperative changes in beta power within the subthalamic nucleus may explain the transient stun effect experienced by patients with Parkinson’s disease after deep brain ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

In a new study, researchers unveil a device that might offer an alternative to invasive procedures. Featuring a novel ultrasound helmet, it not only modulates deep-brain circuits without surgery, but ...

A University of Florida-led study has shown that deep brain stimulation (DBS) significantly improves symptoms and quality of life for Parkinson’s disease patients, with benefits lasting up to five ...